SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-046601
Filing Date
2023-12-29
Accepted
2023-12-29 16:43:06
Documents
17
Period of Report
2023-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63966
2 ex4-1.htm EX-4.1 138450
3 ex10-1.htm EX-10.1 66268
4 ex99-1.htm EX-99.1 19555
5 ex99-1_001.jpg GRAPHIC 2843
  Complete submission text file 0001493152-23-046601.txt   520818

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE envb-20231228.xsd EX-101.SCH 3012
7 XBRL LABEL FILE envb-20231228_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE envb-20231228_pre.xml EX-101.PRE 22357
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 231528234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)